In Vitro Activity of HSR-903, a New Oral Quinolone, against Bacteria Causing Respiratory Infections

The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptoc...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Watanabe, Akira, Tokue, Yutaka, Takahashi, Hiroshi, Kikuchi, Tohru, Kobayashi, Takao, Gomi, Kazunori, Fujimura, Shigeru, Nukiwa, Toshihiro
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1999
Sujets:	Susceptibility
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89361/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390240/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1767
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!